Circular RNA in cancer

VM Conn, AM Chinnaiyan, SJ Conn - Nature Reviews Cancer, 2024 - nature.com
Over the past decade, circular RNA (circRNA) research has evolved into a bona fide
research field shedding light on the functional consequence of this unique family of RNA …

[HTML][HTML] Pathophysiology of acute myeloid leukemia

F Wachter, Y Pikman - Acta Haematologica, 2024 - karger.com
Background: Acute myeloid leukemia (AML) is a biologically heterogenous disease arising
in clonally proliferating hematopoietic stem cells. Sequential acquisition of mutations leads …

Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

A Hernández-Sánchez, T González, M Sobas, E Sträng… - Leukemia, 2024 - nature.com
Balanced rearrangements involving the KMT2A gene (KMT2A r) are recurrent genetic
abnormalities in acute myeloid leukemia (AML), but there is lack of consensus regarding the …

Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias

MC Kwon, JW Thuring, O Querolle, X Dai, T Verhulst… - Blood, 2024 - ashpublications.org
The interaction between menin and histone-lysine N-methyltransferase 2A (KMT2A) is a
critical dependency for KMT2A-or nucleophosmin 1 (NPM1)–altered leukemias and an …

Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement

ZH Gray, D Chakraborty, RR Duttweiler, GD Alekbaeva… - Cell, 2023 - cell.com
Summary MLL/KMT2A amplifications and translocations are prevalent in infant, adult, and
therapy-induced leukemia. However, the molecular contributor (s) to these alterations are …

The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia

E Erkner, T Hentrich, R Schairer, R Fitzel… - Oncogene, 2024 - nature.com
Dysregulated cholesterol homeostasis promotes tumorigenesis and progression. Therefore,
metabolic reprogramming constitutes a new hallmark of cancer. However, until today, only …

Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the …

B Cuglievan, H Kantarjian, JE Rubnitz, TM Cooper… - Leukemia, 2024 - nature.com
Aberrant expression of HOX and MEIS1 family genes, as seen in KMT2A-rearranged,
NUP98-rearranged, or NPM1-mutated leukemias leads to arrested differentiation and …

Risk-stratified therapy for pediatric acute myeloid leukemia

D Tomizawa, SI Tsujimoto - Cancers, 2023 - mdpi.com
Simple Summary Owing to the 40-year worldwide efforts for improving diagnosis and
therapy for acute myeloid leukemia (AML), the second most common type of leukemia in …

MLL oncoprotein levels influence leukemia lineage identities

DH Janssens, M Duran, DJ Otto, W Wu, Y Xu… - Nature …, 2024 - nature.com
Chromosomal translocations involving the mixed-lineage leukemia (MLL) locus generate
potent oncogenic fusion proteins (oncoproteins) that disrupt regulation of developmental …

Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia

J Fischer, E Erkner, R Fitzel, P Radszuweit… - International Journal of …, 2023 - mdpi.com
MLL rearrangement (MLL r) is responsible for the development of acute leukemias with poor
outcomes. Therefore, new therapeutic approaches are urgently needed. The NOTCH1 …